Ana Sánchez de torre

Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status.

G. De Velasco, B. Escudier, P. Barthélémy, 2022, European journal of cancer.

Biology of the Triple-Negative Breast Cancer: Immunohistochemical, RNA, and DNA Features.

E. C. Ciruelos Gil, Ana Sánchez de torre, Mercedes Herrera Juárez, 2020, Breast care.

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study

R. Salazar, J. Brunet, J. Tabernero, 2021, European Journal of Cancer.

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

M. Piccart, M. Filetti, F. Grosso, 2023, The Lancet Oncology.

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

M. Piccart, M. Filetti, R. Salazar, 2021, The Lancet Oncology.

Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer

M. Filetti, F. Mazzoni, G. Lyman, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

M. Piccart, M. Filetti, R. Salazar, 2022, The Lancet Oncology.

Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.

R. Salazar, F. Mazzoni, N. Harbeck, 2021, JAMA oncology.

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

M. Piccart, M. Filetti, F. Mazzoni, 2021, The Lancet. Oncology.

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

M. Filetti, R. Salazar, A. Maconi, 2022, European Journal of Cancer.